Tendyne European Experience Registry
ConditionMitral Regurgitation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLMU Klinikum
About this trial
TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.
Eligibility criteria
Qualifiers
Patients treated with the Tendyne Mitral Valve System for mitral valve disease in a commercial setting
Patients providing written informed consent in compliance with the protocol, the ICH-GCP and all national legal and regulatory requirements
Disqualifiers
Patients not providing written informed consent
Trial design
Treatments tested in this trial
- Tendyne Mitral Valve System
Treatment groups
400 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov